Guangzhou Wondfo BiotechLtd Dividends and Buybacks
Dividend criteria checks 3/6
Guangzhou Wondfo BiotechLtd is a dividend paying company with a current yield of 1.94% that is well covered by earnings.
Key information
1.9%
Dividend yield
-1.7%
Buyback Yield
| Total Shareholder Yield | 0.3% |
| Future Dividend Yield | 1.9% |
| Dividend Growth | 17.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 36% |
Recent dividend and buyback updates
Recent updates
Guangzhou Wondfo Biotech Co.,Ltd (SZSE:300482) Doing What It Can To Lift Shares
Feb 17
These 4 Measures Indicate That Guangzhou Wondfo BiotechLtd (SZSE:300482) Is Using Debt Safely
Jan 17Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture
Nov 18Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 01Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely
Sep 06Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture
Jul 27Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations
Apr 29A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price
Mar 27There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital
Feb 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300482's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300482's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Guangzhou Wondfo BiotechLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300482) | 1.9% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Medical Equipment) | 1.8% |
| Analyst forecast (300482) (up to 3 years) | 1.9% |
Notable Dividend: 300482's dividend (1.94%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
High Dividend: 300482's dividend (1.94%) is low compared to the top 25% of dividend payers in the CN market (2.21%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (35.6%), 300482's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 300482 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/03 23:23 |
| End of Day Share Price | 2025/04/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Guangzhou Wondfo Biotech Co.,Ltd is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Jingwei Qi | China Merchants Securities Co. Ltd. |
| Shuo Song | Citic Securities Co., Ltd. |